Ashland Inc. (ASH) — ESG & Values Scores

Environment story

Ashland has committed to Science Based Targets Initiative (SBTi)-approved 2032 targets aligned with 1.5°C climate warming limits, demonstrating near-term accountability. However, the company discloses material Scope 3 supply-chain emissions from agricultural raw materials (timber, palm, soy) without clear quantification or rising-vs.-flat trending. The 10-K emphasizes climate-related operational risks (coastal storms, water scarcity, deforestation pressure) but provides limited evidence of deep decarbonization capex; environmental reserve adjustments ($34M in 2025, $45M in 2024) suggest ongoing remediation liabilities rather than proactive emission cuts. No disclosure of renewable electricity percentage or Scope 1/2 absolute reductions. Portfolio optimization divested Nutraceuticals and Avoca businesses, reducing overall footprint, but lacks transparent linkage to carbon impact. Net-zero target year is not explicitly stated in 10-K; SBTi 2032 interim target suggests longer-term goal may exceed 2045 boundary.

Criticisms on file

Undisclosed Scope 1 and Scope 2 emissions; no public carbon footprint or emission reduction trajectory reported.
Source: ASH 10-K, Item 1A Risk Factors and MD&A; absence of Sustainability Report or ESG disclosure document in provided sources.
Scope 3 emissions from agricultural supply chain (palm, timber, soy) not quantified; deforestation risk acknowledged but no third-party audit or certification disclosed.
Source: ASH 10-K, Item 1A Risk Factors, 'Climate change and related resource impacts' section.
Environmental remediation reserves adjusted repeatedly ($34M in 2025, $45M in 2024, $56M in 2023) suggest legacy contamination liabilities; specific sites and remediation progress not detailed in 10-K.
Source: ASH 10-K MD&A, 'Use of Non-GAAP Financial Measures' and Notes M (referenced but not fully disclosed in source documents).
No disclosure of renewable electricity percentage or transition away from fossil-fuel-based energy; tariff and trade policy uncertainty (Q2 2025 onward) may increase fossil-fuel sourcing costs or complexity.
Source: ASH 10-K, Item 1A Risk Factors, 'Uncertainty related to tariffs and global trade policy changes' section.

Disclosed initiatives

Science Based Targets Initiative (SBTi) 2032 Targets

Ashland committed to 2032 targets approved by SBTi in October 2023, aligned with limiting global warming to 1.5°C above pre-industrial levels.

Near-term interim milestones; ultimate net-zero year not stated in 10-K.
Supply-Chain Responsible Sourcing

Company acknowledges pressure to source timber, palm, soy, and other agricultural materials responsibly to mitigate deforestation risk and loss of critical habitats.

Commitment stated but no quantified progress metrics or third-party audit results disclosed.
Climate-Related Risk Disclosure

10-K details vulnerability to coastal storms, water scarcity, energy pricing impacts, and supply-chain disruptions from climate change.

Risk management framework acknowledged; operational resilience measures not detailed.

Social story

Ashland reports approximately 2,900 employees globally, with 73% of 2025 sales from outside North America, indicating material exposure to international labor-law variations and cultural-practice compliance challenges. The 10-K acknowledges 'challenges in hiring and maintaining a workforce in certain countries' and 'social and cultural norms in some regions' that may not align with corporate policies, signaling potential labor governance gaps. No disclosed CEO-to-median-worker pay ratio, turnover rate, diversity metrics (executive/board/technical), or union-standing data appears in the provided sources. Ashland mentions environmental reserve liabilities and product-liability exposure (asbestos litigation ongoing), suggesting historical occupational-health risks. No modern slavery statement, supply-chain human-rights audit results, or living-wage commitments documented in 10-K. The company's focus on 'talent succession planning' and 'key personnel retention' reflects human-capital risk awareness but lacks quantified progress on inclusion or equity.

Criticisms on file

No disclosed CEO-to-median-worker pay ratio; compensation data for senior executives not provided in 10-K.
Source: ASH 10-K; proxy statements (not provided in source materials) would typically contain executive compensation details.
No disclosed turnover rate, voluntary/involuntary separation data, or workforce stability metrics for 2,900-person global organization.
Source: ASH 10-K MD&A and Risk Factors; Human Capital disclosures typically found in proxy or sustainability reports (not provided).
No diversity metrics (gender, race/ethnicity) for executive leadership, board, or technical roles; no human-rights or modern slavery audit results disclosed.
Source: ASH 10-K; EEO-1 filing or diversity disclosure typically in proxy or sustainability report (not provided in source materials).
Asbestos litigation ongoing (described as 'pending or threatened claims' with 'substantial amounts' sought); reserves and actual settlements not fully detailed in 10-K excerpts, but legacy occupational-health liability acknowledged.
Source: ASH 10-K, Item 1A Risk Factors, 'Ashland has financial exposure to liabilities from pending and threatened claims, including those alleging personal injury caused by exposure to asbestos'.
No disclosed supply-chain human-rights audit, conflict minerals policy, or living-wage commitment for suppliers; company acknowledges 'challenges in hiring and maintaining a workforce in certain countries' without remediation detail.
Source: ASH 10-K, Item 1A Risk Factors, 'Ashland's substantial global operations' section.

Disclosed initiatives

Talent Succession Planning and Development

Ashland's Risk Factors section emphasizes the importance of identifying and developing talent to succeed senior management and prevent disruption from key-personnel loss.

Stated commitment to knowledge transfer and smooth transitions; no metrics on program effectiveness or diversity of successors disclosed.
Global Workforce Diversity and Compliance

Company acknowledges 'differing labor and employment laws and cultural practices' across 100+ countries and commits to managing a 'diverse workforce across jurisdictions.'

Risk-mitigation framing; no quantified diversity targets, pay-equity analysis, or third-party audit of labor-practice compliance provided.
Health, Safety, and Product Liability Management

Ashland discloses 'extensive federal, state, local and foreign laws' governing human health and safety, with significant costs incurred for compliance and remediation.

Regulatory compliance framework acknowledged; specific OSHA recordables, lost-time injuries, or safety improvement metrics not disclosed in 10-K.

Governance story

Ashland's governance structure lacks transparency on board independence percentage, share-class voting rights, and lobbying expenditures in the provided 10-K excerpt. The company does not disclose whether a dual-class share structure exists (common shares appear to be single-class, but this is not explicitly confirmed). Lobbying spend is not quantified in the 10-K; the company operates in 100+ countries and faces complex tariff, trade, and environmental regulatory landscapes (EU CSRD, EUDR, REACH, GDPR mentioned as evolving compliance burdens) but does not detail legislative advocacy targeting deregulation or rollback. A $706M goodwill impairment in Q3 2025 and $331M Specialty Additives goodwill charge reflect significant valuation pressure and weak acquisition integration history (Nutraceuticals divestiture in 2024 with $107M impairment, Avoca divestiture in 2025 with $175M impairment charge). No active antitrust proceedings disclosed, but substantial asbestos litigation liabilities and environmental remediation reserves ($34M–$56M annual adjustments) indicate ongoing regulatory and legal exposure. SEC filings show stock repurchases of $100M (2025), $380M (2024), $300M (2023)—a total of $780M over three years—which may signal capital allocation toward shareholder returns rather than organic growth or debt reduction.

Criticisms on file

No disclosed board independence percentage or independence committee structure; proxy statement not provided in source materials.
Source: ASH 10-K does not detail board composition; proxy (DEF 14A) would contain this disclosure.
No disclosed annual lobbying expenditures, PAC contributions, or advocacy positions on climate, trade, or environmental regulation; company operates in complex regulatory environments (tariffs, EU ESG rules, REACH, GDPR) but does not detail government-relations activities.
Source: ASH 10-K; lobbying disclosure typically in proxy or separate political-contribution transparency report (not provided).
Goodwill impairment of $706M ($375M Life Sciences, $331M Specialty Additives) in Q3 2025 driven by 'continued decline in market price of Common Stock' and 'slowing growth due to weakening macroeconomic environment'—suggests weak acquisition-integration track record and valuation discipline.
Source: ASH 10-K MD&A, 'Goodwill impairment' section.
Avoca business divestiture (March 2025) with $175M impairment and sale loss; Nutraceuticals business divestiture (August 2024) with $107M impairment—repeated portfolio optimization and write-downs indicate historical M&A misjudgment.
Source: ASH 10-K MD&A, 'Avoca business sale' and 'Key Developments' sections.
Asbestos litigation liabilities ongoing with 'uncertain' reserve estimates based on 'extremely difficult to predict' variables; actual costs could 'adversely affect' results if reserves prove insufficient.
Source: ASH 10-K, Item 1A Risk Factors, 'Ashland has financial exposure to liabilities from pending and threatened claims, including those alleging personal injury caused by exposure to asbestos'.
Environmental remediation reserves adjusted in every reported year ($34M, $45M, $56M for 2025, 2024, 2023 respectively), suggesting ongoing discovery of unknown liabilities or cost estimate volatility at multiple legacy sites.
Source: ASH 10-K MD&A, consolidated statements and 'Use of Non-GAAP Financial Measures' section; Note M referenced but detail not provided in excerpt.

Disclosed initiatives

Regulatory Compliance Framework

Ashland acknowledges exposure to complex federal, state, local, and foreign environmental, health, safety, taxation, and trade regulations across 100+ countries. Company implements compliance controls for FCPA, GDPR, REACH, and evolving ESG disclosure rules (CSRD, CSDDD, EUDR).

Compliance infrastructure noted; specific control effectiveness, audit results, or remediation timelines not detailed.
Risk Management and Disclosure

10-K Risk Factors section details cyber-security threats, intellectual property challenges, product liability, and business continuity planning.

Risk identification comprehensive; mitigation metrics and third-party validation absent.
Capital Allocation Governance

Board-approved stock repurchase program (2023 Stock Repurchase Program) with $100M deployed in 2025, $380M in 2024, and $300M in 2023.

Total of $780M in buybacks over three years; impact on EPS per share reduction noted (54M diluted shares in 2023 to 47M in 2025) but rationale vs. debt reduction or organic investment not explained.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Ashland Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Ashland Inc. in the app for interactive charts and portfolio building.

More in Basic Materials

Linde plc (LIN) Southern Copper Corporation (SCCO) Newmont Corporation (NEM) Freeport-McMoRan Inc. (FCX) The Sherwin-Williams Company (SHW) Ecolab Inc. (ECL)